Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.
about
Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinomaAnalysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyThe use of biologically related model (Eclipse) for the intensity-modulated radiation therapy planning of nasopharyngeal carcinomas.Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinomaEffectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Clinical use of intensity-modulated radiotherapy: part I.Review of monoisocentric split-field technique for conventional and IMRT treatment in head and neck cancers: technical limitations and approaches for optimization.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsRadiotherapy of nasopharyngeal cancer using Rapidarc: dosimetric study of military teaching hospital Mohamed V, MoroccoCurrent and emerging treatment options for nasopharyngeal carcinoma.A novel correction factor based on extended volume to complement the conformity index.New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.Clinical outcome of intensity modulated radiotherapy for carcinoma showing thymus-like differentiationOrgan-sparing radiation therapy for head and neck cancer.Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.Intensity modulated radiotherapy: advantages, limitations and future developments.Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma.IMRT: preliminary results in a series of advanced head-and-neck cancer patients.An evaluation of gating window size, delivery method, and composite field dosimetry of respiratory-gated IMRT.Peripheral dose from megavoltage cone-beam CT imaging for nasopharyngeal carcinoma image-guided radiation therapy.The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma.Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery.Intensity-modulated radiation therapy: First reported treatment in Australasia.Dosimetric study of optimal beam number and arrangement for treatment of nasopharyngeal carcinoma with intensity-modulated radiation therapy.A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery.A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area.The effect of influence quantities and detector orientation on small-field patient-specific IMRT QA: comparison of measurements with various ionization chambers.Intensity-modulated radiation therapy for head and neck cancer.Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.
P2860
Q33689119-8EA8D5F1-95D3-4011-BF4C-ED1035AC47A0Q33889375-E604E4DB-1533-465C-808D-D898460C3102Q33907143-6654A040-DDFB-4BA8-8721-3E6E6B134958Q34015079-3740AA63-3F21-4AFC-A1C4-12C556666F32Q34069855-FCCEAE00-03BA-4237-8337-A3EE9E9ECCDCQ34459534-6692B3B4-B778-4840-A6BF-20D08FC36165Q34587507-5790D61C-1508-475D-BD06-8B0AD54DCD7BQ35114677-D4268377-18A5-4F28-AFA9-82131605CD71Q35534813-23F4BAE2-3097-431F-9EC7-64B992ED8D77Q35686412-56E77513-4838-4F0F-AE57-089748B975C4Q36008502-EFDB7870-75E9-401B-A4E7-7DE7D6E6C2B6Q36065641-6F5EE5D3-28C6-4A67-A0A9-C5024A2E80AFQ36292324-AD968174-F18C-41AE-AA41-3775984A2A92Q36359374-2C1C3D2B-30B3-4DA8-9517-BBE18F6D6BADQ36653139-94C46FF6-D40F-4E4B-9929-5E2D5737BC8FQ36807138-6F442530-FF8E-4A98-8F2A-054236E73757Q37165669-A882E434-7D88-4C53-B037-40ABFAC76646Q37697244-6CBBFF2C-A331-4060-8226-51756DA69084Q37905536-DCA61886-7E11-4777-894C-4509DE1B3857Q38120165-ED867719-B66F-4D36-B304-92AEF4F35B1EQ38251243-AAB7AA05-1D6D-4171-9B82-AB93FCA15022Q38465546-E514943F-5518-4574-BE66-EFE55D6843F8Q40361409-3AF55FC8-E503-483C-AD6C-5D45C2F8B546Q41695908-CE12F0FF-5FB3-4718-AB2B-D3AFCEE3ED00Q41905214-F7E2A064-009E-450F-8213-DCA0128D2FBFQ42510603-4F2BC3E9-1002-442E-A572-1B56F08BD457Q44656605-19E88E77-FDA1-45C0-AAE7-8344C1067C80Q45914162-2C23459E-83E9-4EC7-A2F2-733C399FB36EQ46849880-E3A5CC8F-ECFD-4660-B949-B786DEABE2EBQ46892007-6775A33A-F6D2-4A01-A3F1-A68C78201E5AQ47568633-2F51F0F5-62A2-415B-9C02-5A5E7F3D6C3CQ47638259-3F15A81C-EEAF-4A82-A9C5-2BDB6D86D9C1Q47878816-DCD7B2EB-F233-4E80-AE21-B272CC4DFDF4Q48306237-4F73BF24-3235-4EF5-9C5F-931754B0BC07Q48315053-0099D2FB-D920-4359-B314-F008C0D2C332Q48654789-E8F027F3-6BD2-4560-8778-39B18036611EQ49138961-7A7392D0-8484-4FFA-8094-F92117E65C8CQ50352463-D930FBB6-3E89-45F2-A55A-1199E0FDD6BBQ50434295-57F87980-78A0-41FA-990D-F5A216468BCFQ50438486-39141F63-CC73-49DB-8CD1-01A2DB8E0591
P2860
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Treatment planning and deliver ...... or primary nasopharynx cancer.
@en
Treatment planning and deliver ...... or primary nasopharynx cancer.
@nl
type
label
Treatment planning and deliver ...... or primary nasopharynx cancer.
@en
Treatment planning and deliver ...... or primary nasopharynx cancer.
@nl
prefLabel
Treatment planning and deliver ...... or primary nasopharynx cancer.
@en
Treatment planning and deliver ...... or primary nasopharynx cancer.
@nl
P2093
P50
P1476
Treatment planning and deliver ...... or primary nasopharynx cancer.
@en
P2093
Rosenzweig K
P304
P356
10.1016/S0360-3016(00)01389-4
P407
P577
2001-03-01T00:00:00Z